Potential intestinal infection and faecal–oral transmission of SARS-CoV-2

M Guo, W Tao, RA Flavell, S Zhu - Nature reviews Gastroenterology & …, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to more than
200 countries and regions globally. SARS-CoV-2 is thought to spread mainly through …

Gastroenterology manifestations and COVID‐19 outcomes: A meta‐analysis of 25,252 cohorts among the first and second waves

RM Elshazli, A Kline, A Elgaml… - Journal of Medical …, 2021 - Wiley Online Library
A meta‐analysis was performed to identify patients with coronavirus disease 2019 (COVID‐
19) presenting with gastrointestinal (GI) symptoms during the first and second pandemic …

Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms

AE Livanos, D Jha, F Cossarini, AS Gonzalez-Reiche… - Gastroenterology, 2021 - Elsevier
Background & Aims Given that gastrointestinal (GI) symptoms are a prominent
extrapulmonary manifestation of COVID-19, we investigated intestinal infection with SARS …

Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an …

M Mirani, G Favacchio, F Carrone, N Betella… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Diabetes may unfavorably influence the outcome of coronavirus disease 19
(COVID-19), but the determinants of this effect are still poorly understood. In this monocentric …

Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study

S Weber, JC Hellmuth, C Scherer, M Muenchhoff… - Gut, 2021 - gut.bmj.com
Objective Liver injury has frequently been reported in COVID-19 patients. The clinical
relevance of liver injury related to SARS-CoV-2 infection remains unclear with a need for …

Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients

FR Ponziani, F Del Zompo, A Nesci… - Alimentary …, 2020 - Wiley Online Library
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is
frequently associated with liver test abnormalities. Aims To describe the evolution of liver …

Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and …

M Shehab, F Alrashed, S Shuaibi… - BMJ open …, 2021 - bmjopengastro.bmj.com
Background and aims Patients infected with the SARS-CoV-2 usually report fever and
respiratory symptoms. However, multiple gastrointestinal (GI) manifestations such as …

[HTML][HTML] A mini-review on the impact of COVID 19 on vital organs

MD Shah, AS Sumeh, M Sheraz, MS Kavitha… - Biomedicine & …, 2021 - Elsevier
Abstract COVID-19 (Corona Virus Disease-2019) is an infectious disease caused by a novel
coronavirus, known as the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is …

Gastrointestinal involvement in SARS-CoV-2 infection

TH Chen, MT Hsu, MY Lee, CK Chou - Viruses, 2022 - mdpi.com
SARS-CoV-2 has evolved into a virus that primarily results in mild or asymptomatic disease,
making its transmission more challenging to control. In addition to the respiratory tract, SARS …

Liver tests abnormalities in COVID-19: trick or treat?

E Vespa, N Pugliese, D Piovani… - Journal of …, 2020 - journal-of-hepatology.eu
We read with interest the recent study by Cai et al., 1 which describes the role of liver
function tests (LFTs) in a population of hospitalized patients with COVID-19. The authors' …